Free Trial

Guardant Health (GH) Stock Price, News & Analysis

Guardant Health logo
$64.47 +0.97 (+1.53%)
Closing price 04:00 PM Eastern
Extended Trading
$64.43 -0.04 (-0.06%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Guardant Health Stock (NASDAQ:GH)

Key Stats

Today's Range
$63.44
$65.11
50-Day Range
$40.98
$64.47
52-Week Range
$20.14
$65.11
Volume
1.41 million shs
Average Volume
3.20 million shs
Market Capitalization
$8.04 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$57.50
Consensus Rating
Buy

Company Overview

Guardant Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
66th Percentile Overall Score

GH MarketRank™: 

Guardant Health scored higher than 66% of companies evaluated by MarketBeat, and ranked 391st out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Guardant Health has received a consensus rating of Buy. The company's average rating score is 3.06, and is based on 16 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Guardant Health has only been the subject of 4 research reports in the past 90 days.

  • Read more about Guardant Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Guardant Health are expected to grow in the coming year, from ($2.90) to ($2.84) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Guardant Health is -19.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Guardant Health is -19.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Guardant Health's valuation and earnings.
  • Percentage of Shares Shorted

    8.03% of the float of Guardant Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Guardant Health has a short interest ratio ("days to cover") of 4.
  • Change versus previous month

    Short interest in Guardant Health has recently decreased by 1.88%, indicating that investor sentiment is improving.
  • Dividend Yield

    Guardant Health does not currently pay a dividend.

  • Dividend Growth

    Guardant Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    8.03% of the float of Guardant Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Guardant Health has a short interest ratio ("days to cover") of 4.
  • Change versus previous month

    Short interest in Guardant Health has recently decreased by 1.88%, indicating that investor sentiment is improving.
  • News Sentiment

    Guardant Health has a news sentiment score of 1.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 13 news articles for Guardant Health this week, compared to 10 articles on an average week.
  • Search Interest

    14 people have searched for GH on MarketBeat in the last 30 days. This is an increase of 56% compared to the previous 30 days.
  • MarketBeat Follows

    Only 2 people have added Guardant Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -60% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Guardant Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $11,852,491.00 in company stock.

  • Percentage Held by Insiders

    Only 6.10% of the stock of Guardant Health is held by insiders.

  • Percentage Held by Institutions

    92.60% of the stock of Guardant Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Guardant Health's insider trading history.
Receive GH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Guardant Health and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GH Stock News Headlines

Guardant Health to Host Investor Day on September 24, 2025
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.tc pixel
Analysts Set Guardant Health, Inc. (NASDAQ:GH) Price Target at $57.50
Guardant Health, Inc. (GH) Stock forecasts
See More Headlines

GH Stock Analysis - Frequently Asked Questions

Guardant Health's stock was trading at $30.55 at the start of the year. Since then, GH shares have increased by 111.0% and is now trading at $64.47.

Guardant Health, Inc. (NASDAQ:GH) posted its earnings results on Wednesday, July, 30th. The company reported ($0.44) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.52) by $0.08. The business's revenue for the quarter was up 31.0% compared to the same quarter last year.
Read the conference call transcript
.

Guardant Health (GH) raised $200 million in an initial public offering (IPO) on Thursday, October 4th 2018. The company issued 12,500,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and Cowen, Leerink Partners and William Blair were co-managers.

Guardant Health's top institutional shareholders include Invesco Ltd. (2.85%), Eventide Asset Management LLC (2.77%), Geode Capital Management LLC (2.34%) and ARK Investment Management LLC (2.28%). Insiders that own company stock include Helmy Eltoukhy, Amirali Talasaz, Myrtle S Potter, Kumud Kalia, Meghan V Joyce, Ian T Clark and Musa Tariq.
View institutional ownership trends
.

Shares of GH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Guardant Health investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Salesforce (CRM), Advanced Micro Devices (AMD), CrowdStrike (CRWD) and Adobe (ADBE).

Company Calendar

Last Earnings
7/30/2025
Today
8/28/2025
Next Earnings (Estimated)
11/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Healthcare
Current Symbol
NASDAQ:GH
CIK
1576280
Employees
2,021
Year Founded
N/A

Price Target and Rating

High Price Target
$70.00
Low Price Target
$35.00
Potential Upside/Downside
-10.8%
Consensus Rating
Buy
Rating Score (0-4)
3.06
Research Coverage
17 Analysts

Profitability

EPS (Trailing Twelve Months)
($3.35)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$436.37 million
Net Margins
-49.93%
Pretax Margin
-49.80%
Return on Equity
N/A
Return on Assets
-28.95%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.71
Quick Ratio
3.35

Sales & Book Value

Annual Sales
$739.02 million
Price / Sales
10.88
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($2.45) per share
Price / Book
-26.31

Miscellaneous

Outstanding Shares
124,710,000
Free Float
117,099,000
Market Cap
$8.04 billion
Optionable
Not Optionable
Beta
1.43

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:GH) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners